CUREVAC NV (CVAC)

NL0015436031 - Common Stock

3.13  +0.36 (+13%)

After market: 3.15 +0.02 (+0.64%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
103M
110.63%		67.4M
-34.56%		53.758M
-20.24%		71.908M
33.76%
EBITDA
YoY % growth
-463M
-367.20%		-201.3M
56.52%		-246.302M
-22.36%		-158.625M
35.60%		N/A
EBIT
YoY % growth
-478.7M
-335.97%		-225M
53.00%		-269.688M
-19.86%		-190.383M
29.41%
Operating Margin
-464.76%-333.83%-501.67%-264.76%
EPS
YoY % growth
N/A-1.24N/A-0.93N/A

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.17
35.78%
Revenue
Q2Q % growth		15.308M
114.70%
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-44.998M
25.83%

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth		 -0.22
12.00%		-0.230.015.40%
Q2 2023
Q2Q % growth		 -0.30
3.23%		-0.24-0.06-22.55%
Q1 2023
Q2Q % growth		 -0.27
-237.50%		-0.350.0822.15%
Q4 2022
Q2Q % growth		 -0.60
-∞%		-0.31-0.29-91.30%
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 22.567M
93.05%		34.419M-11.852M-34.43%
Q3 2023
Q2Q % growth		 16.483M
47.04%		17.063M-580K-3.40%
Q2 2023
Q2Q % growth		 7.58M
-62.38%		15.3M-7.72M-50.46%
Q1 2023
Q2Q % growth		 7.13M
-70.74%		13.26M-6.13M-46.23%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% -4.07% -4.07%
Revenue0% 0% 0% 0%